Back to Search
Start Over
Mouse multivalent IgG(2a, b) antibody--ricin A-chain immunotoxins combined with homologous or heterologous interleukin 2 in the treatment of a murine malignant lymphoproliferation (EL4).
- Source :
-
Archivum immunologiae et therapiae experimentalis [Arch Immunol Ther Exp (Warsz)] 1996; Vol. 44 (2-3), pp. 131-6. - Publication Year :
- 1996
-
Abstract
- Two immunotoxins containing ricin A-chain, staphylococcal protein A and mouse anti-Thy 1.2 antibodies of IgG(2a,b) subclass, were prepared. The two multivalent immunotoxins of 750 and 370 kDa and molar ratio A-chain: IgG of 1:2, were used for the treatment of mice bearing ascitic EL4 lymphoma. The immunotoxin-treatment, performed intraperitoneally, was combined or not with homologous or heterologous interleukin 2. The antitumor effects expressed by increase of mice survival time (p < 0.001 as compared with nontreated animals) corresponded to a proportion of 88-90% lymphoma cell-kill by immunotoxin and 93-95% by combination treatment (immunotoxin + interleukin 2), as calculated from the relationship between the survival time of nontreated mice and the number of tumor cells inoculated.
- Subjects :
- Animals
Drug Synergism
Interleukin-2 classification
Mice
Mice, Inbred C57BL
Staphylococcal Protein A therapeutic use
Tumor Cells, Cultured
Immunoglobulin G classification
Immunoglobulin G therapeutic use
Immunoglobulin Isotypes immunology
Immunotoxins therapeutic use
Interleukin-2 therapeutic use
Leukemia, Lymphoid drug therapy
Ricin therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 0004-069X
- Volume :
- 44
- Issue :
- 2-3
- Database :
- MEDLINE
- Journal :
- Archivum immunologiae et therapiae experimentalis
- Publication Type :
- Academic Journal
- Accession number :
- 8915518